Evidence map›Paper›PMID 36192411›Full record

ArticleNature communications2022

Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.

S Parker Singleton, Andrea I Luppi, Robin L Carhart-Harris, Josephine Cruzat, Leor Roseman, David J Nutt, Gustavo Deco, Morten L Kringelbach, Emmanuel A Stamatakis, Amy Kuceyeski

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 1 pooled it
26.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 1 synthesis or guideline pooled it, 145 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Psychedelics and the 'inner healer': Myth or mechanism?Journal of psychopharmacology (Oxford, England) · 2024
    Trial
  5. The entropic brain today.Brain : a journal of neurology · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 7 countries.

S Parker SingletonDepartment of Computational Biology, Cornell University, Ithaca, NY, USA. sps253@cornell.edu.ORCID 0000-0002-7102-7820
Andrea I LuppiDivision of Anesthesia, School of Clinical Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0002-3461-6431
Robin L Carhart-HarrisCenter for Psychedelic Research, Department of Brain Science, Imperial College London, London, UK.
Josephine CruzatLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibanez, Santiago, Chile.ORCID 0000-0002-3252-8657
Leor RosemanCenter for Psychedelic Research, Department of Brain Science, Imperial College London, London, UK.
David J NuttCenter for Psychedelic Research, Department of Brain Science, Imperial College London, London, UK.ORCID 0000-0002-1286-1401
Gustavo DecoCenter for Brain and Cognition, Computational Neuroscience Group, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Roc Boronat 138, Barcelona, Spain.ORCID 0000-0002-8995-7583
Morten L KringelbachDepartment of Psychiatry, University of Oxford, Oxford, UK.ORCID 0000-0002-3908-6898
Emmanuel A StamatakisDivision of Anesthesia, School of Clinical Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0001-6955-9601
Amy KuceyeskiDepartment of Computational Biology, Cornell University, Ithaca, NY, USA.ORCID 0000-0002-5050-8342
Cornell University · USImperial College London · GBUniversity of Cambridge · GBAarhus University · DKInstitució Catalana de Recerca i Estudis Avançats · ESUniversitat Pompeu Fabra · ESUniversity of California, San Francisco · US

Funding

Multi-Modal Imaging of the Mechanisms Underlying Impaired Executive Attention After Traumatic Brain InjuryR01NS102646 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI KUCEYESKI, AMY FRANCES, SHAH, SUDHIN · 2018 to 2022
$2.8M
Heritability and cognitive implications of structural-functional connectome couplingRF1MH123232 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI KUCEYESKI, AMY FRANCES · 2021 to 2021
$1.3M
Quantifying the role of the connectome in resiliency to multiple sclerosisR21NS104634 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI KUCEYESKI, AMY FRANCES · 2017 to 2018
$466k
NIMH NIH HHS RF1 MH123232NINDS NIH HHS R01 NS102646NINDS NIH HHS R21 NS104634
6 · The paper itself

Abstract

Psychedelics including lysergic acid diethylamide (LSD) and psilocybin temporarily alter subjective experience through their neurochemical effects. Serotonin 2a (5-HT2a) receptor agonism by these compounds is associated with more diverse (entropic) brain activity. We postulate that this increase in entropy may arise in part from a flattening of the brain's control energy landscape, which can be observed using network control theory to quantify the energy required to transition between recurrent brain states. Using brain states derived from existing functional magnetic resonance imaging (fMRI) datasets, we show that LSD and psilocybin reduce control energy required for brain state transitions compared to placebo. Furthermore, across individuals, reduction in control energy correlates with more frequent state transitions and increased entropy of brain state dynamics. Through network control analysis that incorporates the spatial distribution of 5-HT2a receptors (obtained from publicly available positron emission tomography (PET) data under non-drug conditions), we demonstrate an association between the 5-HT2a receptor and reduced control energy. Our findings provide evidence that 5-HT2a receptor agonist compounds allow for more facile state transitions and more temporally diverse brain activity. More broadly, we demonstrate that receptor-informed network control theory can model the impact of neuropharmacological manipulation on brain activity dynamics.

Indexed as

HallucinogensLysergic Acid DiethylamideBrainHumansPsilocybinReceptor, Serotonin, 5-HT2ASerotoninSerotonin 5-HT2 Receptor AgonistsHallucinogensLysergic Acid DiethylamidePsilocybinReceptor, Serotonin, 5-HT2ASerotoninSerotonin 5-HT2 Receptor Agonists

Identifiers

PMID36192411
PMCPMC9530221
OpenAlexW4300960088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.